Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

AMREP CORP. (AXR) Form 10-Q — Sep 11, 2026

$AXRForm 10-QFiled Sep 11, 2026, 4:30 PM ET0001104659-26-107084Original filing

AMREP Corporation's fiscal Q1 (quarter ended July 31, 2026) net income fell 94% to $276,000, or $0.05 per diluted share, from $4,692,000, or $0.87 per diluted share, a year earlier. Total revenues dropped 66% to $6.051 million, with land sale revenues down 98% to just $173,000 and home sale revenues down 49% to $4.881 million on 12 homes sold versus 22. The deterioration extended to cash flow: operating activities used $3.634 million versus providing $9.525 million in the prior-year quarter, while G&A expenses rose 30% to $2.408 million, partly due to costs of terminating related-party agreements with TV Investments, LLC (a company 50% owned through an entity of board member Timothy S.

Key figures

Eps
0.05
Revenue
6051000
Net Income
276000
Total Debt
17000
Revenue Yoy
-66%
Total Assets
145656000
Cash Position
48684000
Shares Outstanding
5324849
Homes Sold
12 vs 22 prior year
Ga Expenses
$2,408,000 (up 30% YoY)
Operating Loss
-$163,000 vs operating income of $6,146,000 prior year
Home Sale Revenue
$4,881,000 (down 49% YoY from $9,570,000)
Land Sale Revenue
$173,000 (down 98% YoY from $7,494,000)
Homes In Production
83
Operating Cash Flow
-$3,634,000 vs +$9,525,000 prior year
Homes Under Contract
23, representing $12,505,000 of expected home sale revenues
Shareholders Equity
$141,111,000
Average Selling Price
$407,000 vs $434,000 prior year
Home Sale Gross Margin
23% vs 25% prior year
Land Sale Gross Margin
not meaningful this quarter vs 69% prior year
Tvi Termination Payments
$315,000 total ($201,000 + $114,000) paid to TV Investments, LLC

AI analysis

Red flags7 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    AMREP CORP. (AXR) Form 10-Q — Sep 11, 2026: AI Analysis | Signal8